| Value | ₹0.45 Cr |
|---|
BSE filing, NSE: MACINTR. Summary written from the filing by ALFA Finder's alert engine.
Astal Laboratories Ltd: key numbers
- Share price
- ₹53.05
- Market cap
- ₹223.9 Cr
- Revenue (annual)
- ₹156.0 Cr
- Net profit (annual)
- ₹8.12 Cr
- P/E (TTM)
- 23.0×Sector 45.0×
- Promoter holding
- 4.59%+0.06% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astal Laboratories Ltd
All →Astal Laboratories Other Announcement
Astal Laboratories submitted the Regulation 74(5) certificate from its Registrar for the quarter ended September 30, 2026, confirming the dematerialization activities.
Astal Laboratories Other Announcement
Astal Laboratories' material subsidiary, Sriven Pharmachem India, appointed new Internal, Cost, and Secretarial Auditors. The appointments were approved during the subsidiary's board meeting on September 28, 2026.
Astal Laboratories Management Change
Astal Laboratories Limited has appointed Ms. Ambika Kedia as Company Secretary of its material wholly-owned subsidiary, Sriven Pharmachem India Private Limited. The appointment is effective from September 28, 2026.
Astal Laboratories Annual General Meeting
Astal Laboratories held its 33rd Annual General Meeting on September 29, 2026. Members transacted business regarding financial statements and the re-appointment of a director.
Astal Laboratories Promoter Buying: ₹0.2 Cr
Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.
- Value
- ₹0.20 Cr
- Promoter stake change
- +0.06%
Astal Laboratories Promoter Buying
Astal Laboratories' promoter ACESO Research Labs LLP bought equity shares on BSE under a SEBI PIT disclosure. The open-market purchase signals promoter confidence.
Other capital structure change announcements
All →Mihika Industries Capital Structure Change
Mihika Industries fixed terms for a ₹90 crore partly paid rights issue. Record date is November 6, 2026, at 9 rights shares per share held.
- Value
- ₹90.00 Cr
Swelect Energy Systems Capital Structure Change
SWELECT approved up to Rs 4.36 crore equity infusion into its wholly owned subsidiary. The funds will develop a 4.5 MWp group captive solar plant in Kerala.
- Value
- ₹4.36 Cr
- Execution
- Multiple tranches per the investee company's offer letter
- solar capacity (DC)
- 4.5 MW
Jindal Capital Capital Structure Change
Jindal Capital's board approved rights issue terms for up to Rs 16.22 Crore. The issue opens 17 November 2026 and closes 1 December 2026.
- Value
- ₹16.22 Cr
- Execution
- Issue opens 17 November 2026, closes 1 December 2026
Atul Capital Structure Change
Atul Ltd submitted its daily buy-back report for 2 November 2026, with 4,500 shares bought back at an average price of Rs.5,072.37. Cumulative buy-back spend reached Rs.87.72 Crore of the Rs.90 Crore earmarked.
- Value
- ₹2.28 Cr
Transport Corporation of India Capital Structure Change
Transport Corporation of India extinguished 1,562,500 bought-back equity shares, completing its buyback at Rs 960 per share. The buyback totals about Rs 150 Crore.
- Value
- ₹150.0 Cr
Fine Organic Industries Capital Structure Change
Fine Organic will invest ₹120 Crore in its wholly owned subsidiary Fine Organic Industries (SEZ) for a manufacturing unit. The subsidiary has not yet commenced operations.
- Value
- ₹120.0 Cr